✦ LIBER ✦

Clinical pharmacologic and therapeutic studies of bleomycin given by continuous infusion

✍ Scribed by Irwin H. Krakoff; Esteban Cvitkovic; Violante Currie; Samual Yeh; Charles Lamonte

Publisher: John Wiley and Sons
Year: 1977
Tongue: English
Weight: 720 KB
Volume: 40
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197711)40:5<2027::aid-cncr2820400506>3.0.co;2-a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical pharmacology of bleomycin follo

Clinical pharmacology of bleomycin following intravenous infusion as determined by radioimmunoassay

✍ Alan Broughton; James E. Strong; Paul Y. Holoye; Carlos W. M. Bedrossian 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB

The clinical pharmacology of bleomycin administered by continuous intravenous infusion over a 4 to 5 day period was examined in nine patients. Patients receiving 30 units per day attained an average steady state plasma level of 145.8 (f 43.l)ng/ml bleomycin. Elimination of bleomycin was initially de

A phase I and pharmacology study of cont

A phase I and pharmacology study of continuous-infusion low-dose methotrexate administration

✍ Jacob J. Lokich; Gregory Curt 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 2 views

Studies of hydroxyurea administered by c

Studies of hydroxyurea administered by continuous infusion. Toxicity, pharmacokinetics, and cell synchronization

✍ Robert J. Belt; Charles D. Haas; James Kennedy; Sarah Taylor 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 696 KB

Pharmacology of cytarabine given as a co

Pharmacology of cytarabine given as a continuous infusion followed by mitoxantrone with and without amsacrine/etoposide as reinduction chemotherapy for relapsed or refractory pediatric acute myeloid leukemia

✍ Fevzi Ozkaynak, M.; Avramis, Vassilios I.; Carcich, Sherri; Ortega, Jorge A. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 3 views

Background. The outcome of patients with acute myeloid leukemia (AML) who relapse or fail to achieve an initial remission has been dismal. Procedure. Fifteen pediatric patients with AML, 4 relapsed and 11 primary refractory, were reinduced with a loading bolus of 0.5 g/m 2 cytarabine (ara-C) followe

A phase I study of thiotepa administered

A phase I study of thiotepa administered by short-term and protracted continuous intravenous infusion

✍ Jacob J. Lokich; Merrill J. Egorin; Brian E. Cohen; Murray M. Bern; Thomas E. Zi 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 507 KB

Increasing the dosage of vincristine : A

Increasing the dosage of vincristine : A clinical and pharmacokinetic study of continuous-infusion vincristine in children with central nervous system tumors

✍ Stewart J. Kellie; Pauline Koopmans; John Earl; Christa Nath; Derek Roebuck; Don 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 1 views

## Abstract ## BACKGROUND Vincristine (VCR) is widely used to treat patients with malignant disease; among the patients treated with VCR are children with brain tumors. In vitro studies have demonstrated that the cytotoxic activity of VCR is related to both extracellular concentration and duration